There are problems to be solved industry wide, it's just that bone-marrow derived MSCs have a more significant one to solve. I know its frustrating for you to hear this again, but there is really no other way to chop it.
I actually do not mind if we stick on the subject of safety, as it seems like an important debate.
By way of evidence, CYP has always shown to be the more advanced technology that solves a significant issue in safety and commercialisation... and more.
My money is and always wil be on CYP vs other cell companies/technologies.
There are problems to be solved industry wide, it's just that...
-
- There are more pages in this discussion • 357 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 20.0¢ | $26.24K | 131.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 78722 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 15873 | 1 |
View Market Depth
| Last trade - 15.34pm 16/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |